Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Sell
30,408
-2,885
-9% -$317K 0.2% 93
2026
Q1
$3.5M Sell
33,293
-160
-0.5% -$18.8K 0.24% 87
2025
Q4
$4.17M Sell
33,453
-1,883
-5% -$224K 0.28% 81
2025
Q3
$4.24M Sell
35,336
-1,185
-3% -$125K 0.28% 81
2025
Q2
$3.35M Sell
36,521
-2,297
-6% -$210K 0.24% 92
2025
Q1
$3.42M Buy
38,818
+1,791
+5% +$176K 0.26% 86
2024
Q4
$3.43M Sell
37,027
-1,045
-3% -$101K 0.25% 86
2024
Q3
$3.53M Buy
38,072
+13,435
+55% +$1.13M 0.26% 87
2024
Q2
$1.85M Buy
24,637
+1,632
+7% +$130K 0.14% 106
2024
Q1
$1.98M Buy
+23,005
New +$1.76M 0.15% 109

Other funds holding CRH

Appleton Partners's CRH Position: Q2 2026 in Review

Appleton Partners reduced its CRH (CRH) stake by 8.7% in Q2 2026, selling an estimated $317K and leaving 30,408 shares worth $3.25M. The position accounts for 0.2% of the portfolio, ranked #93.

Appleton Partners first reported a position in CRH in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.24M in Q3 2025. 358 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Appleton Partners held 30,408 shares of CRH worth $3.25M as of Q2 2026.
  • Appleton Partners sold 2,885 CRH shares in Q2 2026, an estimated $317K.
  • CRH made up 0.2% of Appleton Partners's portfolio in Q2 2026, its #93 holding.
  • Appleton Partners first reported a position in CRH in Q1 2024 and has held it in 10 quarters since.
  • Appleton Partners's CRH position peaked at $4.24M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.